Interim C-reactive protein levels predict the prognosis of patients with metastatic colorectal cancer receiving immunotherapy: a retrospective cohort study
Background: Serum C-reactive protein (CRP) level is frequently considered a prognostic predictor of immunotherapy. However, the prognostic role of the interim serum CRP levels before the third course of immunotherapy (CRP-C3) in patients with metastatic colorectal cancer (mCRC) receiving immunothera...
Saved in:
| Main Authors: | Hai-Yan Fu, Yi-Yang Zhang, Jin-Shan Huang, Jin-Xin Hu, Kun-Hao Bai, Zhi-Qiang Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-07-01
|
| Series: | Therapeutic Advances in Medical Oncology |
| Online Access: | https://doi.org/10.1177/17588359251356581 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut markers for metastatic melanoma receiving immunotherapy
by: Guoping Ou, et al.
Published: (2025-07-01) -
Role of telomere maintenance genes as a predictive biomarker for colorectal cancer immunotherapy response and prognosis
by: Zhikai Wang, et al.
Published: (2025-07-01) -
Outcomes of Broader Genomic Profiling in Metastatic Colorectal Cancer: A Portuguese Cohort Study
by: Ricardo Roque, et al.
Published: (2025-01-01) -
Body mass index on survival in metastatic colorectal cancer patients receiving chemotherapy plus bevacizumab: A meta-analysis
by: Lanqing Peng, et al.
Published: (2025-08-01) -
The role of transketolase in the immunotherapy and prognosis of hepatocellular carcinoma: a multi-omics approach
by: Xuan-Yu Gu, et al.
Published: (2025-03-01)